Seth Ettenberg - Net Worth and Insider Trading

Seth Ettenberg Net Worth

The estimated net worth of Seth Ettenberg is at least $0 dollars as of 2024-11-13. Seth Ettenberg is the Chief Scientific Officer of Cogent Biosciences Inc and owns about 0 shares of Cogent Biosciences Inc (COGT) stock worth over $0. Details can be seen in Seth Ettenberg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Seth Ettenberg has not made any transactions after 2019-03-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Seth Ettenberg

To

Seth Ettenberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Seth Ettenberg owns 1 companies in total, including Cogent Biosciences Inc (COGT) .

Click here to see the complete history of Seth Ettenberg’s form 4 insider trades.

Insider Ownership Summary of Seth Ettenberg

Ticker Comapny Transaction Date Type of Owner
COGT Cogent Biosciences Inc 2019-03-25 Chief Scientific Officer

Seth Ettenberg Latest Holdings Summary

Seth Ettenberg currently owns a total of 1 stock. Seth Ettenberg owns 0 shares of Cogent Biosciences Inc (COGT) as of March 25, 2019, with a value of $0.

Latest Holdings of Seth Ettenberg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COGT Cogent Biosciences Inc 2019-03-25 0 10.38 0

Holding Weightings of Seth Ettenberg


Seth Ettenberg Form 4 Trading Tracker

According to the SEC Form 4 filings, Seth Ettenberg has made a total of 0 transactions in Cogent Biosciences Inc (COGT) over the past 5 years. The most-recent trade in Cogent Biosciences Inc is the sale of 2,871 shares on March 25, 2019, which brought Seth Ettenberg around $47,318.

Insider Trading History of Seth Ettenberg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Seth Ettenberg Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Seth Ettenberg Ownership Network

Ownership Network List of Seth Ettenberg

No Data

Ownership Network Relation of Seth Ettenberg

Insider Network Chart

Seth Ettenberg Owned Company Details

What does Cogent Biosciences Inc do?

Who are the key executives at Cogent Biosciences Inc?

Seth Ettenberg is the Chief Scientific Officer of Cogent Biosciences Inc. Other key executives at Cogent Biosciences Inc include 10 percent owner & other: See Remarks Fairmount Funds Management Llc , Chief Legal Officer Evan Kearns , and Chief Financial Officer John L. Green .

Cogent Biosciences Inc (COGT) Insider Trades Summary

Over the past 18 months, Seth Ettenberg made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cogent Biosciences Inc Insider Transactions

No Available Data

Seth Ettenberg Mailing Address

Above is the net worth, insider trading, and ownership report for Seth Ettenberg. You might contact Seth Ettenberg via mailing address: C/o Unum Therapeutics Inc., 200 Cambridge Park Drive Suite 3100, Cambridge Ma 02140.